Differentiated muscle fibres can be formed by transplanted haematopoietic stem cells in models of acute or chronic muscle regeneration, including the dystrophin-deficient mdx mouse. Muscle-forming activity can be found in adult, foetal and embryonic haematopoietic tissues. The blood-to-muscle transition may be due to transdifferentiation of haematopoietic progenitors in response to local signals provided by the regenerating muscle. These signals are only poorly provided by the muscle of the mdx mouse, since transplantation into these mice of normal C57Bl/6 bone mar-row gives rise only to a minimal number of muscle fibres expressing the normal dystrophin protein (<1%) throughout the animal life span. Expansion and active recruitment to myogenic differentiation of transplanted haematopoietic cells are therefore critical factors for a future use of bone marrow transplantation in cell/gene therapy of muscular dystrophy. (C) 2002 Elsevier Science B.V. All rights reserved.

Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? / Ferrari, G; Mavilio, Fulvio. - In: NEUROMUSCULAR DISORDERS. - ISSN 0960-8966. - STAMPA. - 12:(2002), pp. S7-S10. [10.1016/S0960-8966(02)00102-5]

Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy?

MAVILIO, Fulvio
2002

Abstract

Differentiated muscle fibres can be formed by transplanted haematopoietic stem cells in models of acute or chronic muscle regeneration, including the dystrophin-deficient mdx mouse. Muscle-forming activity can be found in adult, foetal and embryonic haematopoietic tissues. The blood-to-muscle transition may be due to transdifferentiation of haematopoietic progenitors in response to local signals provided by the regenerating muscle. These signals are only poorly provided by the muscle of the mdx mouse, since transplantation into these mice of normal C57Bl/6 bone mar-row gives rise only to a minimal number of muscle fibres expressing the normal dystrophin protein (<1%) throughout the animal life span. Expansion and active recruitment to myogenic differentiation of transplanted haematopoietic cells are therefore critical factors for a future use of bone marrow transplantation in cell/gene therapy of muscular dystrophy. (C) 2002 Elsevier Science B.V. All rights reserved.
2002
12
S7
S10
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? / Ferrari, G; Mavilio, Fulvio. - In: NEUROMUSCULAR DISORDERS. - ISSN 0960-8966. - STAMPA. - 12:(2002), pp. S7-S10. [10.1016/S0960-8966(02)00102-5]
Ferrari, G; Mavilio, Fulvio
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/5599
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 37
social impact